Navigation Links
Scripps Research scientists awarded $2.2 million to develop treatment for multi-drug addiction
Date:6/9/2011

The Scripps Research Institute has been awarded a $2.2 million grant from the National Institutes of Health (NIH) to develop novel therapeutics for the treatment of addiction to multiple substances in a national effort with the University of Kansas.

The total award is for $3,698,130, with the Florida campus of Scripps Research receiving $2.19 million over five years and the University of Kansas receiving approximately $1.5 million.

According to the National Survey on Drug Use and Health, in 2009 an estimated 21.8 million Americans aged 12 or older had used illicit drugs within the last month, approximately 8.7 percent of the population aged 12 or older, an increase over 2008. Illicit drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, and prescription-type psychotherapeutics used nonmedically. Multiple drug use is common among substance abusers, according to the National Institute on Drug Abuse (NIDA).

The grant funds research directed by Scripps Research Associate Professor Laura Bohn to develop new compounds targeting a specific receptor playing a critical role in the persistence of compulsive drug seeking and taking. (Receptors bind substances, triggering certain biological effects.)

"All addictive drugs share certain reinforcing properties that make it difficult to quit and remain abstinent," said Bohn. "There is significant evidence spanning decades that the kappa opioid receptor is a good candidate in terms of disrupting this addictive cycle. Right now we're in the early stages of R&D but we have a lot of confidence in what we've studied so far."

The kappa opioid receptor, which is located on neurons, helps regulate the release of dopamine a neurotransmitter that plays a key role in drug addiction. Drugs of abuse often cause the brain to release large amounts of dopamine, flooding the brain's reward system and reinforcing the addictive cycle.

The basis of the studies proposed in the current award results from years of screening by the Molecular Libraries Probe Production Centers Network supported by the NIH. After screening more than 300,000 small molecule compounds, the group, along with the specialized chemistry center at the University of Kansas, identified five novel chemical candidates for clinical development.

For the next five years, the collaborative research team at Scripps Research and the University of Kansas will work to improve selectivity, potency, efficacy, and bioavailability of these compounds to provide a strong preclinical framework for clinical utilization of new drugs targeting the kappa opioid receptor in the hopes of finding a way to help improve recovery from a variety of addictive drugs.


'/>"/>

Contact: Mika Ono
mikaono@scripps.edu
858-784-2052
Scripps Research Institute
Source:Eurekalert

Related biology news :

1. Scripps Research scientist wins $1.9 million grant to study malaria
2. Scripps Research scientists find way to block stress-related cell death
3. Scripps Research scientists find key mechanism in transition to alcohol dependence
4. Scripps Research scientists create new genetic model of premature aging diseases
5. Scripps Research scientists identify mechanism of long-term memory
6. Scripps Research scientists uncover new DNA role in modifying gene function
7. Scripps Research scientists find dual switch regulates fat formation
8. Common chaperone protein found to work in surprising way, say Scripps Research scientists
9. Dr. Daniel Von Hoff presented with top genomics award from Scripps
10. Scripps Research team discovers new details about medically important protein family
11. Scripps Research scientists develop new test for pluripotent stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/18/2016)... 2016 --> --> ... Manned & Unmanned Vehicles, Physical infrastructure and Perimeter Surveillance & ... the border security market and the continuing migration crisis in ... Europe has led visiongain to publish this unique ... --> defence & security companies in the border ...
(Date:3/14/2016)... , March 14, 2016 NXTD ... growing mobile commerce market, announces the airing of a new ... starting the week of March 21 st .  The commercials ... including its popular Squawk on the Street show. --> ... on the growing mobile commerce market, announces the airing of ...
(Date:3/10/2016)... 10, 2016 --> ... report "Identity and Access Management Market by Component (Provisioning, ... Governance), by Organization Size, by Deployment, by Vertical, and ... MarketsandMarkets, The market is estimated to grow from USD ... 2020, at a Compound Annual Growth Rate (CAGR) of ...
Breaking Biology News(10 mins):
(Date:4/29/2016)... , April 29, 2016 ... Transparency Market Research "Separation Systems for Commercial Biotechnology ... Trends, and Forecast 2015 - 2023", the separation ... US$ 10,665.5 Mn in 2014 and is projected ... 2015 to 2023 to reach US$ 19,227.8 Mn ...
(Date:4/29/2016)... ... April 29, 2016 , ... Intelligent Implant Systems announced today that ... 510(k) for sale in the United States. These components expand the capabilities of ... With one-level sales beginning in October of 2015, the company has seen significant sales ...
(Date:4/28/2016)... Q BioMed Inc. (OTCQB:QBIO), ...  was featured in an article he wrote on ... To Tread: http://www.lifescienceleader.com/doc/accelerators-enter-when-vcs-fear-to-tread-0001 ... an essential business journal for life science executives ... Big Pharmas. Their content is designed to inform ...
(Date:4/28/2016)... ... April 28, 2016 , ... As ... recruiting top industry experts, and expanding its LATAM network and logistics capabilities. ... clients to manage their clinical trial projects. , The expansion will provide unmatched ...
Breaking Biology Technology: